Mike Polark

Stock Analyst at Baird

(3.61)
# 839
Out of 5,090 analysts
79
Total ratings
50.98%
Success rate
7.6%
Average return

Stocks Rated by Mike Polark

Inspire Medical Systems
Dec 4, 2025
Maintains: Outperform
Price Target: $125$180
Current: $136.81
Upside: +31.57%
Edwards Lifesciences
Oct 29, 2025
Upgrades: Peer Perform
Price Target: n/a
Current: $86.19
Upside: -
iRhythm Technologies
Oct 10, 2025
Maintains: Outperform
Price Target: $180$220
Current: $178.37
Upside: +23.34%
Medtronic
Jun 30, 2025
Upgrades: Peer Perform
Price Target: n/a
Current: $101.36
Upside: -
Beta Bionics
May 30, 2025
Initiates: Outperform
Price Target: $20
Current: $29.38
Upside: -31.93%
LivaNova
May 20, 2025
Upgrades: Outperform
Price Target: $60
Current: $63.36
Upside: -5.30%
Insulet
May 13, 2025
Upgrades: Outperform
Price Target: $350
Current: $304.49
Upside: +14.95%
Kestra Medical Technologies
Mar 31, 2025
Initiates: Outperform
Price Target: $29
Current: $24.07
Upside: +20.48%
ResMed
Sep 18, 2024
Downgrades: Underperform
Price Target: $180
Current: $256.55
Upside: -29.84%
Zimmer Biomet Holdings
Sep 10, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $94.28
Upside: -
Initiates: Outperform
Price Target: $405
Current: $364.02
Upside: +11.26%
Maintains: Outperform
Price Target: $487$503
Current: $575.34
Upside: -12.57%
Upgrades: Peer Perform
Price Target: n/a
Current: $125.08
Upside: -
Downgrades: Peer Perform
Price Target: n/a
Current: $120.50
Upside: -
Initiates: Outperform
Price Target: $121
Current: $65.49
Upside: +84.76%
Initiates: Peer Perform
Price Target: n/a
Current: $20.92
Upside: -
Upgrades: Outperform
Price Target: $25
Current: $16.75
Upside: +49.25%
Upgrades: Outperform
Price Target: $165
Current: $141.68
Upside: +16.46%
Initiates: Outperform
Price Target: n/a
Current: $97.52
Upside: -
Initiates: Outperform
Price Target: $13
Current: $16.40
Upside: -20.73%
Initiates: Peer Perform
Price Target: $21
Current: $4.89
Upside: +329.45%
Maintains: Outperform
Price Target: $230$250
Current: $263.28
Upside: -5.04%
Initiates: Neutral
Price Target: $43
Current: $0.73
Upside: +5,790.41%